Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

National Drug-Eluting Stent Registry Needed – JAMA Editorial

This article was originally published in The Gray Sheet

Executive Summary

Divergent results from two registries of off-label coronary interventions with drug-eluting stents illustrate the need for a national, standardized registry, according to an editorial in the May 9 Journal of the American Medical Association.
Advertisement

Related Content

NEJM Articles Fuel Debate On Drug-Eluting-Stent Safety
NEJM Articles Fuel Debate On Drug-Eluting-Stent Safety
U.S. DES Use Will Stabilize At Already Lowered Rates, Physicians Suggest
Off-Label Drug-Eluting Stent Data Weak; Label Should Be Revised – Panel
Advertisement
UsernamePublicRestriction

Register

MT024798

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel